Gene expression levels of ITGA2, ITGB1 and ILK were assessed across a previously published breast cancer cohort [65] with respect to regression-free survival (RFS), overall survival (OS), distant metastasis-free survival (DMFS) and progression-free survival (PFS), specifically examining Luminal A breast cancers. The gene discussed is ILK; the disease is breast carcinoma.